Target intelligence / Profile preview

PRXL2C pseudogene 1 (PRXL2CP1)

Target
PRXL2CP1
Molecular classification
Other, Pseudogene
01

Overview

PRXL2CP1 refers to a putative pseudogene related to the PRXL2C gene. Pseudogenes are typically noncoding DNA sequences that resemble genes but lack protein-coding ability, often due to mutations or deletions. Some pseudogenes may have regulatory or non-coding RNA functions, though this is generally rare and not established for PRXL2CP1[3]. There is no evidence that PRXL2CP1 has biological activity, therapeutic relevance, chemical interactions, or validated disease associations. The canonical protein-coding gene in this family is PRXL2C (Peroxiredoxin Like 2C), which has some reported regulatory roles in ERK1/2 and AKT1 signaling and a connection to Fanconi anemia, but this does not extend to PRXL2CP1[1]. The entry appears incorrect for structured target data, and no alternate common aliases, mechanisms, or pharmacological details exist for PRXL2CP1. If you are seeking molecule/receptor information for a therapeutic target, PRXL2CP1 does not qualify under any classification commonly used in drug discovery or molecular biology. If another target is intended, consider verifying the name or consulting experimental databases for more detailed annotation[1][3].

02

Mechanism of action

None

Beyond the preview

Go deeper on PRXL2C pseudogene 1 (PRXL2CP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRXL2C pseudogene 1 (PRXL2CP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call